NRC National Research Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NRC

Price (delayed)

$44.25

Market cap

$1.13B

P/E Ratio

32.07

Dividend/share

$0.12

EPS

$1.38

Enterprise value

$1.11B

Highlights
The quick ratio has surged by 105% year-on-year
National Research's equity has surged by 96% YoY and by 14% QoQ
NRC's net income is down by 7% QoQ and by 3.4% YoY
The EPS has declined by 7% since the previous quarter and by 4.8% year-on-year
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://nrchealth.com/
Peers: NWBO

Key stats

What are the main financial stats of NRC
Market
Shares outstanding
25.44M
Market cap
$1.13B
Enterprise value
$1.11B
Valuations
Price to earnings (P/E)
32.07
Price to book (P/B)
15.36
Price to sales (P/S)
8.34
EV/EBIT
25.57
EV/EBITDA
21.54
EV/Sales
8.24
Earnings
Revenue
$134.88M
EBIT
$43.49M
EBITDA
$51.61M
Free cash flow
$44.89M
Per share
EPS
$1.38
Free cash flow per share
$1.77
Book value per share
$2.88
Revenue per share
$5.31
TBVPS
$3.28
Balance sheet
Total assets
$146.88M
Total liabilities
$73.63M
Debt
$29.61M
Equity
$73.25M
Working capital
$25.3M
Liquidity
Debt to equity
0.4
Current ratio
1.68
Quick ratio
1.56
Net debt/EBITDA
-0.27
Margins
EBITDA margin
38.3%
Gross margin
64%
Net margin
25.8%
Operating margin
32.3%
Efficiency
Return on assets
26.5%
Return on equity
57.9%
Return on invested capital
106.9%
Return on capital employed
39.6%
Return on sales
32.2%
Dividend
Dividend yield
0.27%
DPS
$0.12
Payout ratio
8.7%

NRC stock price

How has the National Research stock price performed over time
Intraday
-1.51%
1 week
-1.36%
1 month
-9.8%
1 year
-20.28%
YTD
3.51%
QTD
-5.51%

Financial performance

How have National Research's revenue and profit performed over time
Revenue
$134.88M
Gross profit
$86.3M
Operating income
$43.5M
Net income
$34.74M
Gross margin
64%
Net margin
25.8%
National Research's net margin has decreased by 8% QoQ and by 7% YoY
NRC's net income is down by 7% QoQ and by 3.4% YoY
NRC's gross profit is up by 3.9% year-on-year and by 2.6% since the previous quarter
National Research's revenue has increased by 3.5% YoY

Growth

What is National Research's growth rate over time

Valuation

What is National Research stock price valuation
P/E
32.07
P/B
15.36
P/S
8.34
EV/EBIT
25.57
EV/EBITDA
21.54
EV/Sales
8.24
The stock's price to earnings (P/E) is 25% less than its 5-year quarterly average of 42.7 and 5% less than its last 4 quarters average of 33.8
The EPS has declined by 7% since the previous quarter and by 4.8% year-on-year
National Research's equity has surged by 96% YoY and by 14% QoQ
NRC's price to book (P/B) is 42% less than its 5-year quarterly average of 26.5 and 30% less than its last 4 quarters average of 21.8
The P/S is 13% lower than the 5-year quarterly average of 9.6 and 11% lower than the last 4 quarters average of 9.4
National Research's revenue has increased by 3.5% YoY

Efficiency

How efficient is National Research business performance
NRC's return on equity is down by 50% year-on-year and by 21% since the previous quarter
The return on assets has declined by 19% year-on-year and by 12% since the previous quarter
NRC's return on invested capital is down by 9% year-on-year but it is up by 5% since the previous quarter
The return on sales has declined by 4.7% year-on-year

Dividends

What is NRC's dividend history
DPS
$0.12
Dividend yield
0.27%
Payout ratio
8.7%
Recent dividends

Financial health

How did National Research financials performed over time
NRC's total assets is 99% greater than its total liabilities
The quick ratio has surged by 105% year-on-year
NRC's current ratio has soared by 91% YoY
National Research's debt is 60% lower than its equity
National Research's equity has surged by 96% YoY and by 14% QoQ
NRC's debt to equity has shrunk by 55% YoY and by 17% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.